Clinical Trial Update: A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of ASP1941 in combination with Nateglinide in Type 2 Diabetes Mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ASP1941
• Nateglinide (nateglinide)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED